AstraZeneca ADR Representing 0.5
Stock
Stock
ISIN: US0463531089
Ticker: AZN
US0463531089
AZN
Price
Price
CHART BY
Historical dividends and forecast
AstraZeneca ADR Representing 0.5 has so far distributed €0.972 in 2025. The next dividend will be paid on 08.09.2025
€0.871
CHART BY
Frequently asked questions
What is AstraZeneca ADR Representing 0.5's market capitalization?
The market capitalization of AstraZeneca ADR Representing 0.5 is €212.51B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is AstraZeneca ADR Representing 0.5's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for AstraZeneca ADR Representing 0.5 is 29.78. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for AstraZeneca ADR Representing 0.5?
AstraZeneca ADR Representing 0.5's Earnings Per Share (EPS) over the trailing twelve months (TTM) is €2.302. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for AstraZeneca ADR Representing 0.5's stock?
Currently, 29 analysts cover AstraZeneca ADR Representing 0.5's stock, with a consensus target price of €79.89. Analyst ratings provide insights into the stock's expected performance.
What is AstraZeneca ADR Representing 0.5's revenue over the trailing twelve months?
Over the trailing twelve months, AstraZeneca ADR Representing 0.5 reported a revenue of €48.52B.
Is AstraZeneca ADR Representing 0.5 paying dividends?
Yes, AstraZeneca ADR Representing 0.5 is paying dividends. The next payment is scheduled for 08.09.2025, with an expected amount of .
What is the EBITDA for AstraZeneca ADR Representing 0.5?
AstraZeneca ADR Representing 0.5's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is €16.11B. EBITDA measures the company's overall financial performance.
What is the free cash flow of AstraZeneca ADR Representing 0.5?
AstraZeneca ADR Representing 0.5 has a free cash flow of €9.86B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does AstraZeneca ADR Representing 0.5 have, and what sector and industry does it belong to?
AstraZeneca ADR Representing 0.5 employs approximately 94,300 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
What is the free float of AstraZeneca ADR Representing 0.5's shares?
The free float of AstraZeneca ADR Representing 0.5 is 3.10B. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- €212.51B
- EPS (TTM)
- €2.302
- Free Float
- 3.10B
- P/E ratio (TTM)
- 29.78
- Revenue (TTM)
- €48.52B
- EBITDA (TTM)
- €16.11B
- Free Cashflow (TTM)
- €9.86B
Pricing
- 1D span
- €68.25€68.50
- 52W span
- €55.93€79.26
Analyst Ratings
The price target is €79.89 and the stock is covered by 29 analysts.
Buy
25
Hold
4
Sell
0
Information
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company’s history roots back to the year 1913 when Astra business was formed. AstraZeneca was founded in 1999 through the merger of Astra AB and Zeneca Group PLC. The company is headquartered in Cambridge, the United Kingdom.
- Employees
- 94,300
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- ISIN
- US0463531089
- Primary Ticker
- AZN
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet